Bay Harbor Wealth Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.12K Buy
60
+13
+28% +$384 ﹤0.01% 634
2026
Q1
$1.3K Buy
47
+27
+135% +$694 ﹤0.01% 679
2025
Q4
$434 Buy
20
+15
+300% +$296 ﹤0.01% 906
2025
Q3
$75 Buy
+5
New +$62 ﹤0.01% 1208

Other funds holding ROIV

Bay Harbor Wealth Management's ROIV Position: Q2 2026 in Review

Bay Harbor Wealth Management increased its Roivant Sciences (ROIV) stake by 28% in Q2 2026, buying an estimated $384 and bringing the position to 60 shares worth $2.12K. The position accounts for ﹤0.01% of the portfolio, ranked #634.

Bay Harbor Wealth Management first reported a position in ROIV in Q3 2025 and has held it in 4 quarters since. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Bay Harbor Wealth Management held 60 shares of Roivant Sciences worth $2.12K as of Q2 2026.
  • Bay Harbor Wealth Management bought 13 Roivant Sciences shares in Q2 2026, an estimated $384.
  • Roivant Sciences made up ﹤0.01% of Bay Harbor Wealth Management's portfolio in Q2 2026, its #634 holding.
  • Bay Harbor Wealth Management first reported a position in Roivant Sciences in Q3 2025 and has held it in 4 quarters since.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Bay Harbor Wealth Management's 13F filing for Q2 2026, filed 28 Jul 2026.